Genetic Risk: Whether, When, and How to Tell Adolescents

Sponsor
Johns Hopkins University (Other)
Overall Status
Completed
CT.gov ID
NCT03421327
Collaborator
National Human Genome Research Institute (NHGRI) (NIH)
85
1
16
5.3

Study Details

Study Description

Brief Summary

This study is being conducted to learn more about family communication of genetic risk information. Semi-structured interviews lasting up to one hour will be conducted with three populations: parent/child pairs at risk for Huntington's Disease, parent/child pairs at risk for hereditary cancer, and genetic counselors.

Detailed Description

The investigators currently lack an adequate understanding of how parents and children feel about genetic risk/status, how it is communicated, and how it influences wellbeing and family relationships. This understanding is vital in order for genetic counselors and other health care professionals to provide the best guidance possible to families. However, little research has been conducted on the impact of genetic risk information or testing on children from the perspective of the child. The research proposed here is uniquely positioned to help fill this gap.

For this study, the investigators will interview 15-20 parent/child pairs who are at risk for Huntington's Disease (HD), 15-20 parent/child pairs who are at risk for hereditary cancer, and 15-20 certified genetic counselors. Interviews will last no more than one hour and will be conducted at a time and place that is convenient for the participant. The investigators will offer participants a choice of conducting the interview in a private conference room at the Berman Institute of Bioethics, or remotely by Skype or telephone. Parents and children will be interviewed separately. Parents will be asked about the decision process behind how and when they disclosed genetic information to their child, style of family communication, advice for other parents in similar situations, and other questions related to the subject of communication of genetic information to minors. Children will be asked about their experience learning genetic risk information, style of family communication, how they felt, advice for other kids in similar situations, and other questions related to the subject of communication of genetic information to minors.

Study Design

Study Type:
Observational
Actual Enrollment :
85 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Genetic Risk: Whether, When, and How to Tell Adolescents
Actual Study Start Date :
Sep 1, 2017
Actual Primary Completion Date :
Dec 31, 2018
Actual Study Completion Date :
Dec 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Families at-risk for HD

No interventions will be administered. Participation involves one semi-structured interview that will last up to one hour. The interview will be scheduled at a time and place that is convenient for the participant. The participant will be given the option to conduct the interview via phone, Skype, or in-person at Johns Hopkins.

Families at-risk for hereditary cancer

No interventions will be administered. Participation involves one semi-structured interview that will last up to one hour. The interview will be scheduled at a time and place that is convenient for the participant. The participant will be given the option to conduct the interview via phone, Skype, or in-person at Johns Hopkins.

Genetic Counselors

No interventions will be administered. Participation involves one semi-structured interview that will last up to one hour. The interview will be scheduled at a time and place that is convenient for the participant. The participant will be given the option to conduct the interview via phone, Skype, or in-person at Johns Hopkins.

Outcome Measures

Primary Outcome Measures

  1. Qualitative analysis of how parents and children with either Huntington's Disease or hereditary cancer communicate about genetic risk information [1.5 years]

    Qualitative interview performed at one occasion where the patient describes when and how genetic risk information was disclosed to minor as well as perspectives from both parent and child.

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Parents at-risk for HD, affected by HD, or be the spouse/partner of someone living who at risk for or affected by HD.

  • Parents who have or have had a diagnosis of hereditary cancer, or the spouse/partner of someone living who has or has had had a diagnosis of hereditary cancer.

  • Children ages 15-17 who are at risk for either HD or hereditary cancer

Exclusion Criteria:
  • Parents and children who have not yet communicated about genetic risk

  • Children younger than age 15

Contacts and Locations

Locations

Site City State Country Postal Code
1 Johns Hopkins Baltimore Maryland United States 21205

Sponsors and Collaborators

  • Johns Hopkins University
  • National Human Genome Research Institute (NHGRI)

Investigators

  • Principal Investigator: Debra Mathews, PhD, MA, Johns Hopkins Berman Institute of Bioeithics

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT03421327
Other Study ID Numbers:
  • IRB00121662
  • R01HG008045
First Posted:
Feb 5, 2018
Last Update Posted:
Feb 7, 2019
Last Verified:
Feb 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 7, 2019